Coverage
-
October 17, 2014
Lannett Company Inc. on Friday asked a Pennsylvania federal judge to slap a shareholder and his attorneys with sanctions for filing and then withdrawing a securities class action alleging that the generic-drug maker's executives hid a scheme to fix prices of the heart failure drug digoxin, contending that the "frivolous" suit was unsupported by facts.
1 other articles on this case.
View all »